
CHOICES – Faces of HIV/AIDS: Diagnosis and Treatment From Planning a Regimen to Managing Your Patient
Bringing Outcomes into Focus: A Learner’s Guide to Translating Theory into Action
The use of highly active antiretroviral therapy (HAART) is very effective in achieving sustained virologic suppression in HIV-infected patients. The result is that HIV infection is now managed as a chronic disease, and near normal longevity is now a realistic treatment goal. Given the significant survival benefits provided by HAART, a number of other issues have assumed a more prominent role in HIV manage¬ment. For example, we now deal with new topics such as immune ac¬tivation, treatment for prevention and long-term toxicity. Additionally, there are the challenges of hepatitis B or hepatitis C coinfection, the consequences of chaotic lives, and the proverbial question of when to start therapy. Another important issue related to treating HIV infection is antiretroviral (ARV) resistance.The advent of new ARV agents offers new treatment options for the difficult-to-treat population of heavily pre-treated HIV-infected patients with resistant infection.
HIV management continues to evolve, as evidenced by frequent updates to recommendations, necessitated by the frequent emergence of new data on novel ARV strategies. Given the rapid changes in state-of-the-art treatments in this field, it can be particularly challenging for health care providers to stay abreast of the latest developments. This educational activity will utilize 4 case-based topics to address scenarios commonly encountered by clinicians who treat patients with HIV infection. Discussion will include how to plan for success in devising HAART strategies in treatment-naive patients, in patients with first-line treatment failure, in those who are treatment experienced, and patients with hepatitis B or hepatitis C coinfection.
Available until June 30, 2011.
Physicians: 1.0 AMA PRA Category 1 Credits™
Nurses: 1.0 contact hour
Pharmacists: 1.0 contact hour (0.1 CEUs)
Presented by the Johns Hopkins University School of Medicine. In cooperation with Global Education Group and Quintiles Medical Education.
[Back to top]
[Back to Activity Home]

|